Very rarely do you get a chance to get in to a company with massive potential in this space that has such a low mc relative to peers and so much short term news on the horizon. CR done now the newsflow can begin. This imho will rerate to fair value once the market wakes up to the massive upside potential. Listening to Mike Harsh, this guy knows what he is talking about. Don't be surprised if this is on the radar of big U.S pharma's.
AIMHO of course
DD
Very rarely do you get a chance to get in to a company with...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
